AIP
OGN icon

ARS Investment Partners’s Organon & Co OGN Stock Holding History

ARS Investment Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-86,332
Closed -$2.02M – 170
2022
Q3 		$2.02M Buy
86,332
+3,415
+4% +$103K 0.28% 55
2022
Q2 		$2.8M Hold
82,917
– – 0.38% 50
2022
Q1 		$2.9M Sell
82,917
-448
-0.5% -$15.3K 0.28% 61
2021
Q4 		$2.54M Sell
83,365
-19,914
-19% -$649K 0.23% 63
2021
Q3 		$3.39M Buy
103,279
+41,295
+67% +$1.32M 0.34% 56
2021
Q2 		$1.88M Buy
+61,984
New +$2.04M 0.19% 63

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ARS Investment Partners's OGN Position: Q4 2022 in Review

ARS Investment Partners sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 86,332 shares — an estimated $2.02M sold.

ARS Investment Partners first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $3.39M in Q3 2021. 821 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

  • ARS Investment Partners reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
  • ARS Investment Partners sold 86,332 Organon & Co shares in Q4 2022, an estimated $2.02M.
  • ARS Investment Partners first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
  • ARS Investment Partners's Organon & Co position peaked at $3.39M in Q3 2021.
  • 821 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on ARS Investment Partners's 13F filing for Q4 2022, filed 25 Jan 2023.